Antitumor effect of hippurate. An experimental study using various mouse tumor strains
Spustová, V.; Oravec, C.
Neoplasma 36(3): 317-320
1989
ISSN/ISBN: 0028-2685 PMID: 2739810 Document Number: 617
Hippurate had antitumor effects both in vitro and in vivo by killing dose-dependently the cells derived from Skalsky lymphoma, Németh-Kellner lymphoma, L-asparaginase sensitive 6C3HED Gardner lymphoma, and LP-2 plasmacytoma. There was no significant difference between the effect of hippurate and its maternal compound benzoate. Hippurate administered intraperitoneally twice a day at a dose of 1 g/kg body weight significantly inhibited the growth of solid 6C3HED Gardner lymphoma even in the case that the treatment was started when the tumors reached a weight of over 400 mg. It was concluded that benzoates could be an important endogenous group of substances with antitumor effects.
Document emailed within 1 workday